Jon Napitupulu

Celularity has entered binding term sheets for a $7 million senior secured term loan and up to $5 million...

Iovance Biotherapeutics granted inducement stock options covering 43,150 shares to four new non-executive employees, effective December 18, 2025, at...

Zenas BioPharma granted inducement stock options covering 300,000 shares to two newly hired employees on December 15, 2025, at...

Boehringer Ingelheim has secured FDA approval for Jascayd (nerandomilast) tablets to treat progressive pulmonary fibrosis (PPF) in adults, the...

Centessa Pharmaceuticals reported positive Phase 2a results for its oral OX2R agonist, ORX750, across narcolepsy type 1, narcolepsy type...

Pharming Group posted a 30% year-over-year revenue increase to $97.3 million in Q3 2025 and lifted full-year guidance to...

Pharmacorp Rx has secured a C$15 million bought deal to fuel its pharmacy roll-up strategy, selling 35.7 million units...

Trethera has secured a $2.7 million NIH Small Business Innovation Research grant to evaluate its first-in-class DCK inhibitor, TRE-515,...

Athira Pharma has licensed global rights (excluding Asia and certain Middle Eastern countries) to lasofoxifene from Sermonix Pharmaceuticals, positioning...

Outlook Therapeutics posted fiscal 2025 results with its first commercial revenue from Lytenava, an ophthalmic formulation of bevacizumab for...